Arcturus Therapeutics Holdings Inc

NASDAQ: ARCT
$15.88
-$0.29 (-1.8%)
Real Time Data Delayed 15 Min.

ARCT Stock Chart and Intraday Price

ARCT Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 10628 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 1,061.72M USD
Shares Outstanding 26,723,300
Arcturus Therapeutics Holdings Inc is a biotechnology firm based in San Diego, California, specializing in the development of innovative mRNA medicines and vaccines. With a focus on addressing infectious diseases, liver, and respiratory rare conditions, Arcturus leverages its proprietary LUNAR lipid-mediated delivery and STARR mRNA technology platforms. The company's pipeline includes ARCT-810, a treatment for ornithine transcarbamylase deficiency in Phase 2 trials, ARCT-154, a COVID-19 vaccine candidate in Phase 3 trials in Vietnam, and ARCT-032, a potential therapy for cystic fibrosis.

ARCT Articles

Markets Settle Into Retail Earnings: Analysts Upgrade or Downgrade Bank of America, Nio and More
Monday’s additional top analyst upgrades and downgrades were on ASML, Bank of America, Dominion Energy, Hasbro, Nio, Occidental Petroleum, Teva Pharmaceutical Industries and more.
Chris Lange
Published:

Friday's Top Analysts Upgrades and Downgrades: AMD, Bilibili, Cognizant, Dynatrace, Equinix, Match, Nutrien, Robinhood, Roku and More
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Bilibili, Cognizant Technologies, Dynatrace, Equinix, Herbalife Nutrition, Match, Nutrien, Robinhood Markets, Roku and...
Lee Jackson
Published:

Does CPI Signal Slowing Inflation? Analysts Upgrade or Downgrade RealReal, Twilio, Vertex Energy and More
Wednesday's additional top analyst upgrades and downgrades were on Okta, RealReal, Twilio, Vertex Energy and more.
Chris Lange
Published:

CPI’s Mixed Report: Analysts Upgrade or Downgrade Carvana, Coinbase, Planet Fitness, Peloton and More
Wednesday’s additional top analyst upgrades and downgrades were on Carvana, Coinbase, Planet Fitness, Peloton and more.
Chris Lange
Published:

Monday Afternoon's Top Analyst Upgrades and Downgrades: Chevron, Netflix, Robinhood, Tesla and More
Monday afternoon's top analyst upgrades and downgrades included Beyond Meat, Chevron, Deutsche Bank, EOG Resources, Kellogg, Microchip Technology, Netflix, Robinhood Markets, Spotify Technology,...
Chris Lange
Published:

Tuesday Afternoon Analyst Upgrades and Downgrades: SmileDirectClub, Squarespace, Victoria's Secret and More
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including Biohaven Pharmaceutical, SmileDirectClub, Squarespace and Victoria’s Secret.
Chris Lange
Published:

Earnings Previews: AMC, New Oriental Education and 3 Cathie Wood Picks
Monday afternoon and Tuesday morning bring earnings reports for five more companies we have been tracking.
Paul Ausick
Published:

Friday's Top Analyst Upgrades and Downgrades: Bloom Energy, Camping World, ContextLogic, National Storage, PNC Financial and More
Friday's top analyst upgrades and downgrades included Bloom Energy, Camping World, ContextLogic, National Storage, PNC Financial and Winnebago.
Chris Lange
Published:

Friday's Top Analyst Upgrades and Downgrades: APA, Arcturus, CME, Darden, First Solar, Logitech, Netflix Nike, Nokia, Sea and More
Friday’s top analyst upgrades and downgrades included APA, Arcturus, CME, Darden, First Solar, Logitech, Netflix Nike, Nokia, Sea, and more.
Chris Lange
Published:

Monday's Top Analyst Upgrades and Downgrades: Accenture, Arcturus, Elastic, Marathon, Riot Blockchain, ResMed, Sykes Enterprises, Western Alliance Bancorp and More
Monday’s top analyst upgrades and downgrades included Accenture, Arcturus, Elastic, Marathon, Riot Blockchain, ResMed, Sykes Enterprises, Western Alliance Bancorp and more.
Chris Lange
Published:

Arcturus Therapeutics, Chesapeake Energy, Square, and More Wednesday Afternoon Analyst Calls
Here's the Wednesday afternoon edition of analysts' upgrades, downgrades and price target changes on several popular stocks.
Paul Ausick
Published: